These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37204209)

  • 1. Comprehensive DNA methylation profiling of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients.
    Shijimaya T; Tahara T; Yamazaki J; Matsumoto Y; Nakamura N; Takahashi Y; Tomiyama T; Fukui T; Shibata T; Naganuma M
    Mol Carcinog; 2023 Aug; 62(8):1191-1200. PubMed ID: 37204209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarchitectures of Barrett's esophagus associated with DNA methylation status.
    Shijimaya T; Tahara T; Yamazaki J; Kobayashi S; Horitani A; Matsumoto Y; Nakamura N; Okazaki T; Takahashi Y; Tomiyama T; Honzawa Y; Fukata N; Fukui T; Naganuma M
    Epigenomics; 2023 Aug; 15(15):759-767. PubMed ID: 37661863
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic profiles of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients.
    Tokunaga M; Okimoto K; Akizue N; Ishikawa K; Hirotsu Y; Amemiya K; Ota M; Matsusaka K; Nishimura M; Matsushita K; Ishikawa T; Nagashima A; Shiratori W; Kaneko T; Oura H; Kanayama K; Ohta Y; Taida T; Saito K; Matsumura T; Chiba T; Mochizuki H; Arai M; Kato J; Ikeda JI; Omata M; Kato N
    Sci Rep; 2021 Sep; 11(1):17671. PubMed ID: 34480065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
    Xu E; Gu J; Hawk ET; Wang KK; Lai M; Huang M; Ajani J; Wu X
    Carcinogenesis; 2013 Dec; 34(12):2750-6. PubMed ID: 23996928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
    Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC
    Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere Shortening of Barrett's Esophagus and Esophageal Adenocarcinoma in Japanese Patients.
    Tahara T; Shijimaya T; Yamazaki J; Tomiyama T; Fukui T; Naganuma M
    Cancer Invest; 2023 Sep; 41(7):640-645. PubMed ID: 37548421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.
    Alvi MA; Liu X; O'Donovan M; Newton R; Wernisch L; Shannon NB; Shariff K; di Pietro M; Bergman JJ; Ragunath K; Fitzgerald RC
    Clin Cancer Res; 2013 Feb; 19(4):878-88. PubMed ID: 23243219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
    Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
    Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
    Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
    Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
    Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
    Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
    Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
    Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium Detected in Barrett's Esophagus and Esophageal Adenocarcinoma Tissues.
    Tahara T; Shijimaya T; Yamazaki J; Kobayashi S; Horitani A; Matsumoto Y; Nakamura N; Okazaki T; Takahashi Y; Tomiyama T; Honzawa Y; Fukata N; Fukui T; Naganuma M
    Cancer Invest; 2024 Jul; 42(6):469-477. PubMed ID: 38913915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
    Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
    Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
    Kaz AM; Wong CJ; Luo Y; Virgin JB; Washington MK; Willis JE; Leidner RS; Chak A; Grady WM
    Epigenetics; 2011 Dec; 6(12):1403-12. PubMed ID: 22139570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
    Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
    Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma.
    Wu W; Bhagat TD; Yang X; Song JH; Cheng Y; Agarwal R; Abraham JM; Ibrahim S; Bartenstein M; Hussain Z; Suzuki M; Yu Y; Chen W; Eng C; Greally J; Verma A; Meltzer SJ
    Gastroenterology; 2013 May; 144(5):956-966.e4. PubMed ID: 23333711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.